NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

john1045,

Affirmative. Of course, a bit more data will come in soon for NWBO. This will change the market cap. DCVAX did not navigate the predictable route that most products take to market. At least since Linda arrived on the scene, they have taken the road less traveled. Infrastructure and manufacturing capacity built well in advance of trial results. Compassionate use programs expanded around the world. Collaborations with prestigious international institutes and governments. FDA approved first in human phase 1/2 trial on All Solid Tumors for DCVAX-Direct. DCVAX-L 2008 follow of 33 patients on phase 2, converted to phase 3 in 2012 with the FDA's blessing. An associated business with an eleven year old canine program for a DCVAX-like program that successfully treats all solid tumors in dogs (probably in every other animal). Linda seems bound and determined to stop big pharma from a hostile takeover (many times CEO's are more interested in a quick buyout).

These are shrewd moves to bring a disruptive technology to market.

Linda managed to keep NWBO shares outstanding low through small frequent dilutions that were not excessive. The market cap is a reflection of a company with a disruptive technology that tried to fly below the radar for a decade while they improved their product and infrastructure. It is little surprise to me that the market place has not been able to establish a value for this company -- simply due to the fact that it breaks the mold.